These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30420449)
1. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Tetzlaff MT; Curry JL; Ning J; Sagiv O; Kandl TL; Peng B; Bell D; Routbort M; Hudgens CW; Ivan D; Kim TB; Chen K; Eterovic AK; Shaw K; Prieto VG; Yemelyanova A; Esmaeli B Clin Cancer Res; 2019 Feb; 25(4):1280-1290. PubMed ID: 30420449 [TBL] [Abstract][Full Text] [Related]
2. NGS Analysis Confirms Common Peterson C; Moore R; Hicks JL; Morsberger LA; De Marzo AM; Zou Y; Eberhart CG; Campbell AA Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445161 [TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813 [TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis. Xu S; Moss TJ; Laura Rubin M; Ning J; Eterovic K; Yu H; Jia R; Fan X; Tetzlaff MT; Esmaeli B Mod Pathol; 2020 Jul; 33(7):1256-1263. PubMed ID: 31937901 [TBL] [Abstract][Full Text] [Related]
5. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas. Ramberg I; Vieira FG; Toft PB; von Buchwald C; Funding M; Nielsen FC; Heegaard S Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):11. PubMed ID: 34779821 [TBL] [Abstract][Full Text] [Related]
6. Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma. Bao Y; Selfridge JE; Wang J; Zhao Y; Cui J; Guda K; Wang Z; Zhu Y J Genet Genomics; 2019 Jun; 46(6):315-318. PubMed ID: 31278009 [No Abstract] [Full Text] [Related]
7. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma. Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525 [TBL] [Abstract][Full Text] [Related]
8. HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive Tract. Williams EA; Montesion M; Lincoln V; Tse JY; Hiemenz MC; Mata DA; Shah BB; Shoroye A; Alexander BM; Werth AJ; Foley-Peres K; Milante RR; Ross JS; Ramkissoon SH; Williams KJ; Adhikari LJ; Zuna RE; LeBoit PE; Lin DI; Elvin JA Am J Surg Pathol; 2022 Jun; 46(6):729-741. PubMed ID: 35034043 [TBL] [Abstract][Full Text] [Related]
10. Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer. Macedo J; Silva E; Nogueira L; Coelho R; da Silva J; Dos Santos A; Teixeira-Júnior AA; Belfort M; Silva G; Khayat A; de Oliveira E; Dos Santos AP; Cavalli LR; Pereira SR Mol Carcinog; 2020 Jun; 59(6):604-617. PubMed ID: 32212199 [TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus and ZEB1 in ocular adnexal sebaceous carcinoma. Moore RF; Zhang XR; Allison DB; Rooper LM; Campbell AA; Eberhart CG J Cutan Pathol; 2021 Aug; 48(8):1027-1033. PubMed ID: 33745190 [TBL] [Abstract][Full Text] [Related]
12. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892 [TBL] [Abstract][Full Text] [Related]
13. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer. Manzano RG; Catalan-Latorre A; Brugarolas A BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103 [TBL] [Abstract][Full Text] [Related]
14. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma. Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242 [TBL] [Abstract][Full Text] [Related]
15. Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors. Merten L; Agaimy A; Moskalev EA; Giedl J; Kayser C; Geddert H; Schaefer IM; Cameron S; Werner M; Ströbel P; Hartmann A; Haller F Am J Clin Pathol; 2016 Dec; 146(6):718-726. PubMed ID: 28028119 [TBL] [Abstract][Full Text] [Related]
17. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217 [TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations. Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232 [TBL] [Abstract][Full Text] [Related]
19. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes. Offin M; Chan JM; Tenet M; Rizvi HA; Shen R; Riely GJ; Rekhtman N; Daneshbod Y; Quintanal-Villalonga A; Penson A; Hellmann MD; Arcila ME; Ladanyi M; Pe'er D; Kris MG; Rudin CM; Yu HA J Thorac Oncol; 2019 Oct; 14(10):1784-1793. PubMed ID: 31228622 [TBL] [Abstract][Full Text] [Related]
20. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer. Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]